Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/36420
Title: Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data
Authors: Dayan, Colin
Lecumberri, Beatriz
Muller, Ilaria
Ganesananthan, Sashiananthan
Hunter, Samuel F.
Selmaj, Krzysztof W.
Hartung, Hans-Peter
Havrdova, Eva K.
LaGanke, Christopher C.
Ziemssen, Tjalf
VAN WIJMEERSCH, Bart 
Meuth, Sven G.
Margolin, David H.
Afsar, Salman
Daizadeh, Nadia
Poole, Elizabeth M.
Baker, Darren P.
Senior, Peter A.
Issue Date: 2021
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Source: NEUROLOGY, 96 (15) (Art N° 1509)
Document URI: http://hdl.handle.net/1942/36420
ISSN: 0028-3878
e-ISSN: 1526-632X
ISI #: 000729283600255
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events_ 6-Year Pooled CARE-MS Data (1509) _ Neurology.pdf
  Restricted Access
Published version2.19 MBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

60
checked on Jun 13, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.